US Patent Issued to Boehringer Ingelheim International on Jan. 20 for "Pharmaceutical composition, methods for treating and uses thereof" (German, Canadian, American Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,810, issued on Jan. 20, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Pharmaceutical composition, methods for treating and uses thereof" was invented by Peter Eickelmann (Mittelbiberach, Germany), Michael Mark (Biberach an der Riss, Germany), Leo John Seman (Cheshire, Conn.), Leo Thomas (Biberach an der Riss, Germany), Uli Christian Broedl (Oakville, Canada) and Rolf Grempler (Mittelbiberach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose to...